Neolife SA Valuation
| ALNLF Stock | EUR 0.06 0.0009 1.45% |
Neolife SA seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Neolife SA from analyzing the firm fundamentals such as Return On Equity of -0.33, profit margin of (0.05) %, and Current Valuation of 3.6 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Neolife SA's price fluctuation is out of control at this time. Calculation of the real value of Neolife SA is based on 3 months time horizon. Increasing Neolife SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Neolife SA's intrinsic value may or may not be the same as its current market price of 0.06, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0629 | Real 0.0509 | Hype 0.06 |
The intrinsic value of Neolife SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Neolife SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Neolife SA helps investors to forecast how Neolife stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Neolife SA more accurately as focusing exclusively on Neolife SA's fundamentals will not take into account other important factors: Neolife SA Total Value Analysis
Neolife SA is presently projected to have takeover price of 3.6 M with market capitalization of 3.14 M, debt of 1.93 M, and cash on hands of 691.45 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Neolife SA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.6 M | 3.14 M | 1.93 M | 691.45 K |
Neolife SA Investor Information
The company has price-to-book (P/B) ratio of 1.28. Some equities with similar Price to Book (P/B) outperform the market in the long run. Neolife SA recorded a loss per share of 0.01. The entity had not issued any dividends in recent years. The firm had 648:403 split on the 13th of August 2015. Based on the key measurements obtained from Neolife SA's financial statements, Neolife SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Neolife SA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Neolife SA has an asset utilization ratio of 172.47 percent. This connotes that the Company is making €1.72 for each dollar of assets. An increasing asset utilization means that Neolife SA is more efficient with each dollar of assets it utilizes for everyday operations.Neolife SA Profitability Analysis
The company reported the revenue of 10.72 M. Net Loss for the year was (169.34 K) with profit before overhead, payroll, taxes, and interest of 3.43 M.About Neolife SA Valuation
The stock valuation mechanism determines Neolife SA's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Neolife SA based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neolife SA. We calculate exposure to Neolife SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Neolife SA's related companies.Its solutions enable architects, landscapists, design offices, and building technicians to meet environmental specification packages for HQE , BREEAM, and LEED projects for individual and multi-unit housing, commercial buildings, and urban spaces. The company was incorporated in 2012 and is headquartered in Limonest, France. Neolife SA is traded on Paris Stock Exchange in France.
8 Steps to conduct Neolife SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Neolife SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Neolife SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Neolife SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Neolife SA's revenue streams: Identify Neolife SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Neolife SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Neolife SA's growth potential: Evaluate Neolife SA's management, business model, and growth potential.
- Determine Neolife SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Neolife SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Neolife Stock Analysis
When running Neolife SA's price analysis, check to measure Neolife SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neolife SA is operating at the current time. Most of Neolife SA's value examination focuses on studying past and present price action to predict the probability of Neolife SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neolife SA's price. Additionally, you may evaluate how the addition of Neolife SA to your portfolios can decrease your overall portfolio volatility.